{
    "SPADE_UN_12121": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_12121",
            "Peptide Name": "NBC2253 (De Novo Synthesis)",
            "Source": "synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "CGIYRSLKLIKSLVLIK",
            "Sequence Length": 17,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.31119600] Gram-positive bacteria:MRSA(MIC=6.7 ± 0.02µM);Gram-negative bacteria:Escherichia coli O157:H7(MIC=25 ± 0.03µM)",
            "Hemolytic Activity": "[Ref.31119600] No hemolytic activity against bovine blood cells",
            "Cytotoxicity": "[Ref.31119600] The cell viability of Vero ATCC CCL 1-81 cells induced by NBC2253 is 87.8%, 66.4%, 62.2%, 69.1% and 68.8% at peptide concentrations of 1.2, 3.7, 11.1, 33.3 and 100 μM.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "The sulfhydryl side chain of the cysteine residue was conjugated to AuNC(previously modified with SPDP) via a disulfide bond.",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C91H163N23O21S",
            "Mass": 1947.47,
            "PI": 10.03,
            "Net Charge": 4,
            "Hydrophobicity": 0.94,
            "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.",
            "Literature": [
                {
                    "Title": "New Synthetic Peptides Conjugated to Gold Nanoclusters Antibiotic Activity Against Escherichia coli O157H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).",
                    "Pubmed ID": "31119600",
                    "Reference": "Protein J. 2019 May 22. doi 10.1007/s10930-019-09840-9.",
                    "Author": "Prada YA, Guzmán F, Ortíz C, Cabanzo R, Torres R, Mejía-Ospino E",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31119600"
                },
                {
                    "Title": "new Synthetic Peptides Conjugated to Gold nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA)",
                    "Pubmed ID": "",
                    "Author": "Prada YA, Guzm��n F, Ortiz C, Cabanzo R, Torres R, Mejia-Ospino E"
                }
            ],
            "Frequent Amino Acids": "LIK",
            "Absent Amino Acids": "ADEFHMNOPQTUW",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 9,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_22753",
                    "Similarity": 1.0,
                    "Sequence": "KLIK"
                },
                {
                    "SPADE_ID": "SPADE_N_12773",
                    "Similarity": 0.8235294117647058,
                    "Sequence": "SFIKRSLKLIKSLVLIK"
                },
                {
                    "SPADE_ID": "SPADE_UN_20467",
                    "Similarity": 0.8235294117647058,
                    "Sequence": "SFIKRSLKLIKSLVLIK"
                }
            ]
        }
    }
}